Sylvia Hartmann
-
- Lymphoma Diagnosis and Treatment 8
-
- Cancer Immunotherapy and Biomarkers 2
-
- Chronic Lymphocytic Leukemia Research 3
- Genomics and Rare Diseases 1
-
- Lung Cancer Treatments and Mutations 3
-
- Cardiac tumors and thrombi 2
-
- Autoimmune Neurological Disorders and Treatments 1
-
- Radiomics and Machine Learning in Medical Imaging 1
- Co-authors
- Anke DollerW. EberhardtJosef PfeilschifterSebastian SchulzMartin‐Leo HansmannSebastian NewrzelaClaudia DöringChristoph Renné
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Sylvia Hartmann
13 papers receiving 125 citations
Peers
Comparison fields: 5 of 43
- Pathology and Forensic Medicine 29
- Oncology 33
- Cancer Research 16
- Emergency Medical Services 7
- Genetics 10
Countries citing papers authored by Sylvia Hartmann
This map shows the geographic impact of Sylvia Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Hartmann more than expected).
Fields of papers citing papers by Sylvia Hartmann
This network shows the impact of papers produced by Sylvia Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Hartmann. The network helps show where Sylvia Hartmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sylvia Hartmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 3 | |
| 10 | 2018 | 0 | |
| 11 | 2016 | 18 | |
| 12 | 2014 | 4 | |
| 13 | 2013 | 13 | |
| 14 | 2013 | 8 | |
| 15 | 2011 | 52 | |
| 16 | 2006 | 10 | |
| 17 | Myocardial ischaemia and reperfusion in the anaesthetised pig: reduction of infarct size and myocardial enzyme release by the stable prostacyclin analogue iloprost. | 1989 | 3 |
About Sylvia Hartmann
Sylvia Hartmann is a scholar working on Pathology and Forensic Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 126 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cardiac tumors and thrombi (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Autoimmune Neurological Disorders and Treatments (1 paper), Genomics and Rare Diseases (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (29 citations), Oncology (33 citations) and Cancer Research (16 citations). Sylvia Hartmann has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Anke Doller, W. Eberhardt, Josef Pfeilschifter, Sebastian Schulz, Martin‐Leo Hansmann, Sebastian Newrzela, Claudia Döring, Christoph Renné, Stefan Dröse and Karen L. Rice. Their work appears in journals such as Blood, European Heart Journal and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.